NAFDAC Investigates Alleged Presence of Substandard Paracetamol in Nigerian Markets
The National Agency for Food and Drug Administration and Control (NAFDAC) is currently conducting an investigation into the reported
The National Agency for Food and Drug Administration and Control (NAFDAC) is currently conducting an investigation into the reported existence of counterfeit and substandard paracetamol brands in the open market in Nigeria. This comes in the wake of widespread concerns following viral reports suggesting that a significant portion of paracetamol tablets sold in Nigeria may be under-dosed.
In an official statement released yesterday, Prof Mojisola Adeyeye, the Director-General of NAFDAC, announced that the agency has initiated a comprehensive market survey to collect and analyze samples of various paracetamol brands available across the country.
While dismissing the research findings as inaccurate and describing the scientific methodology as questionable, Adeyeye clarified that NAFDAC is taking the matter seriously and has already engaged with the leadership of the Pharmaceutical Manufacturing Group of the Manufacturing Association of Nigeria (PMG-MAN) to communicate the agency’s actions and intentions.
The statement, titled “Nearly All Paracetamol Tablets in Nigeria Possibly Under-Dosed: Initial NAFDAC Response,” confirms NAFDAC’s awareness of the research publication and outlines the agency’s commitment to ensuring the safety and efficacy of pharmaceutical products in the Nigerian market.
Quest: Cris-Edesiri Odjomah